Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received a boost on news of the launch of a new portfolio of assays. Elsewhere there were decent results from a software group and an exceptional investment gain from a private equity investor.
Draper Esprit: another big investment success
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Draper Esprit PLC
Venture Capital Play | Brain Health Contracts
A venture capital group covered here is raising new funds to take advantage of the buoyant…
Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received…
More on IDOX
Horror show | No deal | Bonkers Bargain delights
News covered here included our assessment of results from a provider of software to the public…
Growth aplenty | Free cash flow focus | Low ball offer
There have been plenty of trading updates and results to digest with one of our Bonkers…
More on Novacyt SA
Impressive results | Trading well | Little to cheer
News covered here includes our assessment of excellent results from a provider of compliance and e-learning…
A refocused business delivers
Having survived a near death experience several years ago, a manufacturer of specialist industrial equipment covered…
More on SEC SpA
Investing success and new assays
After a volatile start to 2021, the share price of last year’s top AIM performer received…
